Jump to content
  • Sign Up
0
Scott Adams

Microtest Laboratories Will Manufacture ImmusanT's Nexvax2 Immunotherapeutic ... - MarketWatch (press release)

Rate this topic

Recommended Posts

Microtest Laboratories Will Manufacture ImmusanT's Nexvax2 Immunotherapeutic ...

MarketWatch (press release)

ImmusanT recently raised $20 million in financing to advance the development of their technology, Nexvax2, for the treatment of celiac disease. Celiac disease is an inherited autoimmune disorder that is triggered by the consumption of foods containing ...

View the full article

Share this post


Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
0

×